Nicotinamide Mononucleotide (NMN) Market Emerging Trends & New Growth Opportunities - Forecast 2025-2031 | At a CAGR of 13.4%

Los Angeles, United States - QY Research has unveiled its latest study titled "Global Nicotinamide Mononucleotide (NMN) Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031." This newly released report delivers a comprehensive overview of the global Nicotinamide Mononucleotide (NMN) market, analyzing the forces shaping its growth trajectory and providing valuable insights for stakeholders, investors, and industry professionals. the research covers key areas including market dynamics, segmentation, regional performance, competitive landscape, and emerging technology trends that are redefining industry standards. Backed by reliable data and expert analysis, the report serves as a trusted guide to understanding both microeconomic and macroeconomic factors driving market evolution.

The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.

Download Free Sample PDF Report (with full TOC, tables, and charts) To Explore Detailed Insights and Forecasts @ https://qyresearch.in/request-sample/chemical-material-nicotinamide-mononucleotide-nmn-global-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.

With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.

At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.

Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.

Competitive Landscape: -

GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
ABA Chemical

The competitive landscape is a must-have information for the market players to withstand the competition present in the global Nicotinamide Mononucleotide (NMN) market. This further helps the market participants to develop effective strategies to optimize their market positions. Moreover, the competitive analysis helps them to determine potential advantages as well as barriers within the global Nicotinamide Mononucleotide (NMN) market. This way, they can monitor how their competitors are implementing various strategies including pricing, marketing, and distribution.

Market Drivers and Restraints -

This section of the Nicotinamide Mononucleotide (NMN) report discusses various drivers and restrains that have shaped the global market. The detailed study of numerous drivers of the market enable readers to get a clear perspective of the market, which includes market environment, government policies, product innovations, breakthroughs, and market risks.

The research report also points out the myriad opportunities, challenges, and market barriers present in the global Nicotinamide Mononucleotide (NMN) market. The comprehensive nature of the information will help the reader determine and plan strategies to benefit from. Restrains, challenges, and market barriers also help the reader to understand how the company can prevent itself from facing downfall.

Regional Insights -

The report takes readers on a journey through four key regions: United States, Asia-Pacific, and EMEA. Key nations like the United States, Germany, the United Kingdom, China, Japan, South Korea, and more are thoroughly examined. The data is presented in a timeline from 2024 as the base year, with projections extending to 2031.

North America: United States, Canada, Mexico

Latin America: Brazil and other key markets

Asia Pacific: China, Japan, South Korea, India, ASEAN countries

Europe, Middle East & Africa (EMEA): Major European economies, GCC countries, and African nations

The report provides a region-wise breakdown of market share, consumption trends, and future prospects.

Detailed of Nicotinamide Mononucleotide (NMN) Market Segmentation -

The report offers great insights into important segments of the global Nicotinamide Mononucleotide (NMN) market while concentrating on their CAGR, market size, market share, and future growth potential. The global Nicotinamide Mononucleotide (NMN) market is mainly segmented according to type of product, application, and region. Each segment in these categories is extensively researched to become familiar with their growth prospects and key trends. Segmental analysis is highly important to identify key growth pockets of a global market. The report provides specific information on the market growth and demand of different products and applications to help players to focus on profitable areas of the global Nicotinamide Mononucleotide (NMN) market.

Segmentation By Type :-

Content greater than or equal to 98%
Content less than 98%

Segmentation By Application -

Health Care Products
Cosmetics
Others

This segmentation helps identify high-growth opportunities and niche segments for investors and businesses.

Request for Pre-Order Enquiry On This Exclusive Report @ https://qyresearch.in/pre-order-inquiry/chemical-material-nicotinamide-mononucleotide-nmn-global-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Why This Report is a Must-Have -

ᗒ Historical Analysis (2020-2024) & Forecasts (2025-2031): Gain a clear understanding of market trends and future growth potential.

ᗒ Comprehensive Market Segmentation: Detailed breakdown by Type, Application, and Region to identify lucrative opportunities.

ᗒ Competitive Landscape: Insights into key players, their market share, and strategic developments like mergers, acquisitions, and expansion plans.

ᗒ Drivers & Restraints: Understand the factors shaping the market's growth and the challenges that could impact your strategy.

ᗒ Expert Opinions & Market Dynamics: Benefit from expert analysis to navigate market risks and capitalize on emerging trends.

Nicotinamide Mononucleotide (NMN) Market Report Objectives -

(1) Analyzing the size of the global Nicotinamide Mononucleotide (NMN) market on the basis of value and volume

(2) Accurately calculating the market shares, consumption, and other vital factors of different segments of the global Nicotinamide Mononucleotide (NMN) market

(3) Exploring key dynamics of the global Nicotinamide Mononucleotide (NMN) market

(4) Highlighting important trends of the global Nicotinamide Mononucleotide (NMN) market in terms of production, revenue, and sales

(5) Deeply profiling top players of the global Nicotinamide Mononucleotide (NMN) market and showing how they compete in the industry

(6) Studying manufacturing processes and costs, product pricing, and various trends related to them

(7) Showing the performance of different regions and countries in the global Nicotinamide Mononucleotide (NMN) market

(8) Forecasting the market size and share of all segments, regions, and the global market.

Important Questions Answered included in the Report:-

(A) What is the market size and growth rate of the global and regional market by various segments?

(B) What is the market size and growth rate of the market for selective Countries?

(C) Which region or sub-segment is expected to drive the market in the forecast period?

(D) What factors are estimated to drive and restrain the market growth?

(E) What are the key technology and market trends shaping the market?

(F) what are the key opportunity in the market?

(G) Who are the leading manufacturers operating in the global Nicotinamide Mononucleotide (NMN) market?

(H) Which key player accounted for the highest market share?

(I) What are the growth opportunities for the new entrants in the global Nicotinamide Mononucleotide (NMN) market?

Table of Contents - Major Key Points:

1 Market Overview
1.1 Nicotinamide Mononucleotide (NMN) Product Introduction
1.2 Global Nicotinamide Mononucleotide (NMN) Market Size Forecast
1.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value (2020-2031)
1.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume (2020-2031)
1.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Price (2020-2031)
1.3 Nicotinamide Mononucleotide (NMN) Market Trends & Drivers
1.3.1 Nicotinamide Mononucleotide (NMN) Industry Trends
1.3.2 Nicotinamide Mononucleotide (NMN) Market Drivers & Opportunity
1.3.3 Nicotinamide Mononucleotide (NMN) Market Challenges
1.3.4 Nicotinamide Mononucleotide (NMN) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nicotinamide Mononucleotide (NMN) Players Revenue Ranking (2024)
2.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025)
2.3 Global Nicotinamide Mononucleotide (NMN) Players Sales Volume Ranking (2024)
2.4 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Company Players (2020-2025)
2.5 Global Nicotinamide Mononucleotide (NMN) Average Price by Company (2020-2025)
2.6 Key Manufacturers Nicotinamide Mononucleotide (NMN) Manufacturing Base and Headquarters
2.7 Key Manufacturers Nicotinamide Mononucleotide (NMN) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nicotinamide Mononucleotide (NMN)
2.9 Nicotinamide Mononucleotide (NMN) Market Competitive Analysis
2.9.1 Nicotinamide Mononucleotide (NMN) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Nicotinamide Mononucleotide (NMN) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide (NMN) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Content greater than or equal to 98%
3.1.2 Content less than 98%
3.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Type
3.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Type (2020-2031)
3.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Type (%) (2020-2031)
3.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type
3.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (2020-2031)
3.3.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (%) (2020-2031)
3.4 Global Nicotinamide Mononucleotide (NMN) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Health Care Products
4.1.2 Cosmetics
4.1.3 Others
4.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Application
4.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Application (2020-2031)
4.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Application (%) (2020-2031)
4.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application
4.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (2020-2031)
4.3.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (%) (2020-2031)
4.4 Global Nicotinamide Mononucleotide (NMN) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region
5.1.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2020-2025)
5.1.3 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2026-2031)
5.1.4 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), (2020-2031)
5.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region
5.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2020-2025)
5.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2026-2031)
5.2.4 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (%), (2020-2031)
5.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
5.4.2 North America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
5.5.2 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
5.6.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
5.7.2 South America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
5.8.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value and Sales Volume
6.2.1 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.3.2 United States Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.4.2 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.5.2 China Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.6.2 Japan Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.7.2 South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.8.2 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.9.2 India Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 GeneHarbor
7.1.1 GeneHarbor Company Information
7.1.2 GeneHarbor Introduction and Business Overview
7.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Product Offerings
7.1.5 GeneHarbor Recent Development
7.2 Herbalmax
7.2.1 Herbalmax Company Information
7.2.2 Herbalmax Introduction and Business Overview
7.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Product Offerings
7.2.5 Herbalmax Recent Development
7.3 Genex Formulas
7.3.1 Genex Formulas Company Information
7.3.2 Genex Formulas Introduction and Business Overview
7.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Product Offerings
7.3.5 Genex Formulas Recent Development
7.4 Mirailab Bioscience
7.4.1 Mirailab Bioscience Company Information
7.4.2 Mirailab Bioscience Introduction and Business Overview
7.4.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Product Offerings
7.4.5 Mirailab Bioscience Recent Development
7.5 Maac10 Formulas
7.5.1 Maac10 Formulas Company Information
7.5.2 Maac10 Formulas Introduction and Business Overview
7.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Offerings
7.5.5 Maac10 Formulas Recent Development
7.6 EffePharm
7.6.1 EffePharm Company Information
7.6.2 EffePharm Introduction and Business Overview
7.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Product Offerings
7.6.5 EffePharm Recent Development
7.7 Bontac
7.7.1 Bontac Company Information
7.7.2 Bontac Introduction and Business Overview
7.7.3 Bontac Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Bontac Nicotinamide Mononucleotide (NMN) Product Offerings
7.7.5 Bontac Recent Development
7.8 CELFULL
7.8.1 CELFULL Company Information
7.8.2 CELFULL Introduction and Business Overview
7.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Product Offerings
7.8.5 CELFULL Recent Development
7.9 Kingdomway
7.9.1 Kingdomway Company Information
7.9.2 Kingdomway Introduction and Business Overview
7.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Product Offerings
7.9.5 Kingdomway Recent Development
7.10 ABA Chemical
7.10.1 ABA Chemical Company Information
7.10.2 ABA Chemical Introduction and Business Overview
7.10.3 ABA Chemical Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 ABA Chemical Nicotinamide Mononucleotide (NMN) Product Offerings
7.10.5 ABA Chemical Recent Development
8 Industry Chain Analysis
8.1 Nicotinamide Mononucleotide (NMN) Industrial Chain
8.2 Nicotinamide Mononucleotide (NMN) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nicotinamide Mononucleotide (NMN) Sales Model
8.5.2 Sales Channel
8.5.3 Nicotinamide Mononucleotide (NMN) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.